Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Bulgarian hospital group to raise €40m for expansion

City Hospital, the second-largest private Bulgarian hospital group, plans to raise €40m to build two new hospitals. We talk to CEO Ilian Grigorov about the group, the Bulgarian market and the future. Ilian and his colleagues will also be joining us at the annual Healthcare Europa conference on March 13, 2014.
January 20, 2014

Donors turn to private healthcare sector to deliver better outcomes

Many charitable donors are looking to use the private sector to deliver healthcare services to poor- and middle-income countries. Why? What are the potential road-blocks, and what does this mean for private operators? We report on a meeting on the subject, organised by the Center for Global Development, in London in January 2014.
January 17, 2014

Competition Commission still plans to carve up HCA in London but Spire escapes

HCA emerges as the big loser from the latest version of the Competition Commission's plans for the UK hospital sector. It would be forced to sell two of its six London hospitals, which together represent 30% of the company's sales. We look at the other winners and losers in the new verdict, and how hospital sales could reconfigure the London market.
January 16, 2014

More Irish troubles

Further troubles have emerged in the Irish private hospital sector. A new report shows that the sustainability of private medical insurance is threatened as the number of young enrollees drops.
January 15, 2014

FREE BLOG Filling the vacuum

It is striking that there are no more than a handful of private hospitals focused on private, self-funding patients in Russia and the former Warsaw Pact countries.
January 13, 2014

Turkven buys majority of Medical Park

Carlyle and its co-owners have sold a 65% stake in Medical Park to Turkish private equity group Turkven, the second-largest Turkish hospital chain by sales, in a deal valuing Medical Park at nearly $1bn (€730m). We look at valuations, EBITDA and the company's future strategy.
January 12, 2014

Amedes buys Medivision

Amedes, the big German lab group, has bought Medivision, the endocrinology chain, from the receivers. We reveal the sum paid, and look at EBITDA margins. How does this fit with the ongoing sale of Amedes?
January 10, 2014

Fresenius clears way for Rhoen deal and targets big business

Helios - soon to become by far Europe’s largest private hospital chain, with sales of €5.5bn - has made peace with rival Asklepios and supplier B Braun. We look at its ambitious plans to capture tens of thousands of new patients with a drive to sell supplementary insurance to Germany’s largest employers.
January 6, 2014
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us